Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Diabetes/Metabolism Research and Reviews|July 21, 2018
Glycemic variability in the development of cardiovascular complications in diabetesAnnunziata Nusca, Dario Tuccinardi, Marzia Albano, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 14, 2016
Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL studyFabio Mangiacapra, Iginio Colaiori, Elisabetta Ricottini, et al.
The American Journal of Cardiology|May 3, 2011
Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trialGiuseppe Patti, Elisabetta Ricottini, Annunziata Nusca, et al.
The American Journal of Cardiology|August 13, 2016
Relation of Neutrophil to Lymphocyte Ratio With Periprocedural Myocardial Damage in Patients Undergoing Elective Percutaneous Coronary InterventionEdoardo Bressi, Fabio Mangiacapra, Elisabetta Ricottini, et al.
The American Journal of Cardiology|March 12, 2022
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes StatusIlaria Cavallari, Giuseppe Patti, Ernesto Maddaloni, et al.
JACC. Cardiovascular Interventions|March 20, 2010
Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary interventionFabio Mangiacapra, Emanuele Barbato, Giuseppe Patti, et al.
The American Journal of Cardiology|March 30, 2013
Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP study)Giuseppe Patti, Fabio Mangiacapra, Elisabetta Ricottini, et al.
Journal of Molecular and Cellular Cardiology|February 20, 2002
Apoptosis and post-infarction left ventricular remodelingAlfonso Baldi, Antonio Abbate, Rossana Bussani, et al.
Platelets|August 27, 2013
Thresholds for platelet reactivity to predict clinical events after coronary intervention are different in patients with and without diabetes mellitusFabio Mangiacapra, Aaron Peace, Emanuele Barbato, et al.
The American Journal of Cardiology|January 9, 2016
Effect of High-Dose Atorvastatin Reload on the Release of Endothelial Progenitor Cells in Patients on Long-Term Statin Treatment Who Underwent Percutaneous Coronary Intervention (from the ARMYDA-EPC Study)Elisabetta Ricottini, Rosalinda Madonna, Domenico Grieco, et al.
Pageof 8